Vivifi Device Safety Evaluation for the Treatment of Benign Prostatic Hyperplasia (NCT07745621)

🧪 Interventions in This Study

• Minimally invasive percutaneous ablation (DEVICE)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Hospital Paitilla — Panama City, Provincia de Panamá

📞 Contact the Study Coordinator

Phone: (503) 757-5281

Email: dan@vivifimedical.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Benign Prostatic Hyperplasia

• PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs — La Mesa, California
• Comparing UroLift Experience Against Rezūm — Los Angeles, California
• Expander-2 Trial: Randomized Study to Evaluate Safety & Efficacy of the Urocross® Expander System & Retrieval Sheath — Maywood, Illinois
• Optilume™ BPH Catheter System in Men With Symptomatic BPH — Little Rock, Arkansas
• Investigation of Prostate Artery Embolization Compared to Holmium Laser Enucleation of Prostate — Miami, Florida
• Laser Prostatectomy Database and Registry — Indianapolis, Indiana

Explore by condition: All Benign Prostatic Hyperplasia clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.